These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 5581646)
1. [Desmofibrinolytic activity of blood]. Zuch A Postepy Hig Med Dosw; 1971; 25(1):89-128. PubMed ID: 5581646 [No Abstract] [Full Text] [Related]
2. Significance of the thiol groups in the formation of desmofibrin. Buluk K; Zuch A Pol Med J; 1971; 10(4):886-94. PubMed ID: 5126382 [No Abstract] [Full Text] [Related]
3. [Factor XIII, its physiological significance (a review of the literature)]. Baluda VP; Zhukova NA Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):34-40. PubMed ID: 4271843 [No Abstract] [Full Text] [Related]
5. Factor XIII consumption as an indicator of thrombin generation. Triantaphyllopoulos DC J Lab Clin Med; 1974 Jul; 84(1):74-80. PubMed ID: 4833844 [No Abstract] [Full Text] [Related]
6. [Changes in the properties of fibrinogen as a result of blood loss]. Zhankina GKh Vestn Khir Im I I Grek; 1972 Sep; 109(9):80-3. PubMed ID: 4664064 [No Abstract] [Full Text] [Related]
7. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation]. Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of desmofibrinogenic activity and FSF (factor XIII of blood coagulation) level in plasma of healthy children in various age groups]. Zuch A; Zwierzowa W; Rudobielska M; Buluk K Pediatr Pol; 1972 Oct; 47(10):1205-11. PubMed ID: 5085406 [No Abstract] [Full Text] [Related]
9. [Desmofibrinogenic activity of factor XIII and plasma concentration of thiol groups in the course of systemic scleroderma]. Zuch A; Pietruska Z; Bogdanikowa B; Buluk K Reumatologia; 1979; 17(4):457-63. PubMed ID: 531372 [No Abstract] [Full Text] [Related]
10. Effect of fibrinogen and Ca2+ on the thrombin-catalyzed proteolytic event that triggers activation of factor XIII. Shafer JA; Lewis SD; Janus TJ; Lorand L Ann N Y Acad Sci; 1986; 485():134-9. PubMed ID: 3471144 [No Abstract] [Full Text] [Related]
11. Generation and mechanism of action of a potent inhibitor of factor XIII function. Reed GL; Lukacova D Thromb Haemost; 1995 Aug; 74(2):680-5. PubMed ID: 8585006 [TBL] [Abstract][Full Text] [Related]
12. Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor. Curtis CG; Brown KL; Credo RB; Domanik RA; Gray A; Stenberg P; Lorand L Biochemistry; 1974 Aug; 13(18):3774-80. PubMed ID: 4859234 [No Abstract] [Full Text] [Related]
13. [Fibrinase and antifibrinolytic activity of the blood in patients with laryngeal cancer]. Brovko TE; Kizim AI Zh Ushn Nos Gorl Bolezn; 1971; 31(3):12-6. PubMed ID: 5569849 [No Abstract] [Full Text] [Related]
14. Fibrin-stabilizing factor (factor XIII) in the fetus and the newborn infant. Henriksson P; Hedner U; Nilsson IM; Boehm J; Robertson B; Lorand L Pediatr Res; 1974 Sep; 8(9):789-91. PubMed ID: 4413463 [No Abstract] [Full Text] [Related]
15. Activity of coagulation and fibrinolysis parameters in animals. Karges HE; Funk KA; Ronneberger H Arzneimittelforschung; 1994 Jun; 44(6):793-7. PubMed ID: 8053983 [TBL] [Abstract][Full Text] [Related]
16. Role of calcium ion in the generation of factor XIII activity. Hornyak TJ; Shafer JA Biochemistry; 1991 Jun; 30(25):6175-82. PubMed ID: 2059625 [TBL] [Abstract][Full Text] [Related]
17. Desmofibrin formation and the activity of the fibrin stabilizing factor (FSF) during the cleavage of its SH groups by thrombin. Buluk K; Olbromski J; Januszko T; Zuch A Thromb Diath Haemorrh; 1966 Jul; 16(1):51-60. PubMed ID: 5989050 [No Abstract] [Full Text] [Related]
19. Calcium and thiol reactivity of human plasma clotting factor XIII. Cooke RD; Pestell TC; Holbrook JJ Biochem J; 1974 Sep; 141(3):675-82. PubMed ID: 4463957 [TBL] [Abstract][Full Text] [Related]
20. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease. Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]